Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:10 pm Unchanged | 2024-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Venrock Healthcare Capital Partners III, L.P. | 0 0.000% | 0 (Unchanged) | Filing |